Notably, we assembled a clinical cohort sample to validate the pivotal gene for cuproptosis, FDX1, to supply more clues to translate the biological significance of cuproptosis in ccRCC. This evidence concerns the gene FDX1 and nonpapillary renal cell carcinoma.